Synchron Raises $200 Million Series D to Enhance Brain-Computer Interface Technology
Synchron has secured $200 million in its Series D funding round to accelerate the commercialization of its Stentrode™ brain-computer interface (BCI) platform. This new investment will also support the expansion of the company’s AI and engineering divisions in New York and San Diego.
Media Contact
- Name: Kimberly Ha
- Email: [email protected]
“Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego.”
Author’s Summary
Synchron’s latest funding round strengthens its position in brain-computer interface innovation, paving the way for broader commercial adoption and technological growth.